Literature DB >> 11755021

Olfactory impairment increases as a function of age in persons with Down syndrome.

Rani K Nijjar1, Claire Murphy.   

Abstract

Neuropathology similar to that found in the brains of patients with Alzheimer's disease (AD) has consistently been observed in older individuals with Down syndrome (DS) and this neuropathology is particularly prevalent in areas involved in olfaction. The present study investigated the effects of age on the expression of olfactory impairment in Down syndrome to address the hypothesis that older adults with DS show greater deficits in olfactory function compared with younger persons with DS and compared with age and IQ matched control groups. Between group differences showed that persons with DS had significant deficits in olfactory functioning compared to the two control groups. Further, within the DS group, older adults performed more poorly than the young adults or children. Results support the hypothesis that in a group of persons at risk for AD because of DS, olfactory impairment is greater in older individuals, suggesting progressive impairment over time. Deficits in olfactory function may be useful in signalling incipient dementia in DS.

Entities:  

Mesh:

Year:  2002        PMID: 11755021     DOI: 10.1016/s0197-4580(01)00263-9

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  10 in total

1.  Olfactory deficits, cognition and negative symptoms in early onset psychosis.

Authors:  Cheryl Corcoran; Agnes Whitaker; Eliza Coleman; Jane Fried; Judith Feldman; Nora Goudsmit; Dolores Malaspina
Journal:  Schizophr Res       Date:  2005-08-26       Impact factor: 4.939

2.  Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome.

Authors:  Fabio M Simoes de Souza; Nicolas Busquet; Megan Blatner; Kenneth N Maclean; Diego Restrepo
Journal:  Sci Rep       Date:  2011-11-02       Impact factor: 4.379

3.  Olfaction in three genetic and two MPTP-induced Parkinson's disease mouse models.

Authors:  Stefan Kurtenbach; Sonja Wewering; Hanns Hatt; Eva M Neuhaus; Hermann Lübbert
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

Review 4.  Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations.

Authors:  Katheleen J Gardiner
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

5.  Nasal neuron PET imaging quantifies neuron generation and degeneration.

Authors:  Genevieve C Van de Bittner; Misha M Riley; Luxiang Cao; Janina Ehses; Scott P Herrick; Emily L Ricq; Hsiao-Ying Wey; Michael J O'Neill; Zeshan Ahmed; Tracey K Murray; Jaclyn E Smith; Changning Wang; Frederick A Schroeder; Mark W Albers; Jacob M Hooker
Journal:  J Clin Invest       Date:  2017-01-23       Impact factor: 14.808

6.  Modeling Down Syndrome with Patient iPSCs Reveals Cellular and Migration Deficits of GABAergic Neurons.

Authors:  Hai-Qin Huo; Zhuang-Yin Qu; Fang Yuan; Lixiang Ma; Lin Yao; Min Xu; Yao Hu; Jing Ji; Anita Bhattacharyya; Su-Chun Zhang; Yan Liu
Journal:  Stem Cell Reports       Date:  2018-03-08       Impact factor: 7.765

Review 7.  Development of Down Syndrome Research Over the Last Decades-What Healthcare and Education Professionals Need to Know.

Authors:  Karin Windsperger; Stefanie Hoehl
Journal:  Front Psychiatry       Date:  2021-12-14       Impact factor: 4.157

8.  Olfaction in People with Down Syndrome: A Comprehensive Assessment across Four Decades of Age.

Authors:  Maria Paola Cecchini; Dario Viviani; Marco Sandri; Antje Hähner; Thomas Hummel; Carlo Zancanaro
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

9.  Hypocellularity in the Murine Model for Down Syndrome Ts65Dn Is Not Affected by Adult Neurogenesis.

Authors:  Rosa López-Hidalgo; Raul Ballestín; Jessica Vega; José M Blasco-Ibáñez; Carlos Crespo; Javier Gilabert-Juan; Juan Nácher; Emilio Varea
Journal:  Front Neurosci       Date:  2016-03-02       Impact factor: 4.677

Review 10.  Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management.

Authors:  Kenji Kondo; Shu Kikuta; Rumi Ueha; Keigo Suzukawa; Tatsuya Yamasoba
Journal:  Front Aging Neurosci       Date:  2020-07-07       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.